The Cooper Companies, Inc.

NasdaqGS:COO Stok Raporu

Piyasa değeri: US$21.1b

Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

Cooper Companies Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 4/6

Cooper Companies şirketinin kazançları yıllık ortalama -14.7% oranında azalırken, Medical Equipment sektörünün kazançları yıllık 11.5% oranında artan oldu. Gelirler yıllık ortalama 9.4% oranında artan oldu. Cooper Companies şirketinin öz sermaye getirisi 4.5% olup, net marjı 9.4% dir.

Anahtar bilgiler

-14.7%

Kazanç büyüme oranı

-14.8%

EPS büyüme oranı

Medical Equipment Sektör Büyümesi8.9%
Gelir büyüme oranı9.4%
Özkaynak getirisi4.5%
Net Marj9.4%
Sonraki Kazanç Güncellemesi05 Dec 2024

Yakın geçmiş performans güncellemeleri

Recent updates

Are Investors Undervaluing The Cooper Companies, Inc. (NASDAQ:COO) By 35%?

Oct 01
Are Investors Undervaluing The Cooper Companies, Inc. (NASDAQ:COO) By 35%?

Returns On Capital At Cooper Companies (NASDAQ:COO) Paint A Concerning Picture

Sep 15
Returns On Capital At Cooper Companies (NASDAQ:COO) Paint A Concerning Picture

The Cooper Companies: Still An Expensive Place

Aug 26

Investors Interested In The Cooper Companies, Inc.'s (NASDAQ:COO) Earnings

Aug 17
Investors Interested In The Cooper Companies, Inc.'s (NASDAQ:COO) Earnings

Is There Now An Opportunity In The Cooper Companies, Inc. (NASDAQ:COO)?

Jul 30
Is There Now An Opportunity In The Cooper Companies, Inc. (NASDAQ:COO)?

Is There An Opportunity With The Cooper Companies, Inc.'s (NASDAQ:COO) 36% Undervaluation?

Jun 20
Is There An Opportunity With The Cooper Companies, Inc.'s (NASDAQ:COO) 36% Undervaluation?

Cooper Companies: Business Growth Noted, Valuations An Ask

Jun 14

Investors Could Be Concerned With Cooper Companies' (NASDAQ:COO) Returns On Capital

May 21
Investors Could Be Concerned With Cooper Companies' (NASDAQ:COO) Returns On Capital

With The Cooper Companies, Inc. (NASDAQ:COO) It Looks Like You'll Get What You Pay For

May 02
With The Cooper Companies, Inc. (NASDAQ:COO) It Looks Like You'll Get What You Pay For

Should You Think About Buying The Cooper Companies, Inc. (NASDAQ:COO) Now?

Apr 17
Should You Think About Buying The Cooper Companies, Inc. (NASDAQ:COO) Now?

The Cooper Companies: Rating Upgrade As Near-Term Momentum Should Continue

Mar 22

Calculating The Intrinsic Value Of The Cooper Companies, Inc. (NASDAQ:COO)

Mar 18
Calculating The Intrinsic Value Of The Cooper Companies, Inc. (NASDAQ:COO)

The Cooper Companies: I Still Don't See Much Upside

Mar 01

These 4 Measures Indicate That Cooper Companies (NASDAQ:COO) Is Using Debt Reasonably Well

Jan 23
These 4 Measures Indicate That Cooper Companies (NASDAQ:COO) Is Using Debt Reasonably Well

Cooper Companies: Women Health Business Makes Room For Growth; Path For Margin Expansion

Jan 15

When Should You Buy The Cooper Companies, Inc. (NASDAQ:COO)?

Jan 08
When Should You Buy The Cooper Companies, Inc. (NASDAQ:COO)?

With The Cooper Companies, Inc. (NASDAQ:COO) It Looks Like You'll Get What You Pay For

Dec 24
With The Cooper Companies, Inc. (NASDAQ:COO) It Looks Like You'll Get What You Pay For

A Look At The Fair Value Of The Cooper Companies, Inc. (NASDAQ:COO)

Nov 30
A Look At The Fair Value Of The Cooper Companies, Inc. (NASDAQ:COO)

Investors Could Be Concerned With Cooper Companies' (NASDAQ:COO) Returns On Capital

Oct 30
Investors Could Be Concerned With Cooper Companies' (NASDAQ:COO) Returns On Capital

What Does The Cooper Companies, Inc.'s (NASDAQ:COO) Share Price Indicate?

Sep 28
What Does The Cooper Companies, Inc.'s (NASDAQ:COO) Share Price Indicate?

Cooper Offers A Great Business But A Somewhat Tricky Valuation

Sep 25

Here's Why Cooper Companies (NYSE:COO) Can Manage Its Debt Responsibly

Sep 10
Here's Why Cooper Companies (NYSE:COO) Can Manage Its Debt Responsibly

Calculating The Fair Value Of The Cooper Companies, Inc. (NYSE:COO)

Aug 23
Calculating The Fair Value Of The Cooper Companies, Inc. (NYSE:COO)

Cooper Companies (NYSE:COO) Is Reinvesting At Lower Rates Of Return

Jul 24
Cooper Companies (NYSE:COO) Is Reinvesting At Lower Rates Of Return

The Cooper Companies: Valuation Is Too High (Rating Downgrade)

Jul 12

When Should You Buy The Cooper Companies, Inc. (NYSE:COO)?

Jun 24
When Should You Buy The Cooper Companies, Inc. (NYSE:COO)?

Is Cooper Companies (NYSE:COO) Using Too Much Debt?

Jun 08
Is Cooper Companies (NYSE:COO) Using Too Much Debt?

Estimating The Intrinsic Value Of The Cooper Companies, Inc. (NYSE:COO)

May 24
Estimating The Intrinsic Value Of The Cooper Companies, Inc. (NYSE:COO)

Investors Could Be Concerned With Cooper Companies' (NYSE:COO) Returns On Capital

Apr 23
Investors Could Be Concerned With Cooper Companies' (NYSE:COO) Returns On Capital

At US$355, Is The Cooper Companies, Inc. (NYSE:COO) Worth Looking At Closely?

Mar 25
At US$355, Is The Cooper Companies, Inc. (NYSE:COO) Worth Looking At Closely?

These 4 Measures Indicate That Cooper Companies (NYSE:COO) Is Using Debt Reasonably Well

Feb 04
These 4 Measures Indicate That Cooper Companies (NYSE:COO) Is Using Debt Reasonably Well

Cooper Companies: Growth Comes At A High Cost To Equity Holders, Rate Hold

Jan 30

Estimating The Fair Value Of The Cooper Companies, Inc. (NYSE:COO)

Jan 19
Estimating The Fair Value Of The Cooper Companies, Inc. (NYSE:COO)

Investors Could Be Concerned With Cooper Companies' (NYSE:COO) Returns On Capital

Jan 04
Investors Could Be Concerned With Cooper Companies' (NYSE:COO) Returns On Capital

Cooper Cos. initiated at buy at Mizuho on contact lenses, cataract implants positioning

Dec 22

Is It Too Late To Consider Buying The Cooper Companies, Inc. (NYSE:COO)?

Dec 20
Is It Too Late To Consider Buying The Cooper Companies, Inc. (NYSE:COO)?

The Cooper Companies declares $0.03 dividend

Dec 14

The Cooper Companies Non-GAAP EPS of $2.75 misses by $0.36, revenue of $848.1M beats by $9.22M

Dec 08

Cooper Companies: Questions On Viability Of Future Earnings Upside

Nov 04

Are Investors Undervaluing The Cooper Companies, Inc. (NYSE:COO) By 38%?

Oct 18
Are Investors Undervaluing The Cooper Companies, Inc. (NYSE:COO) By 38%?

BioSkryb, Cooper ink license deal for genomic technology for women's reproductive health

Oct 18

Be Wary Of Cooper Companies (NYSE:COO) And Its Returns On Capital

Oct 03
Be Wary Of Cooper Companies (NYSE:COO) And Its Returns On Capital

Gelir ve Gider Dağılımı

Cooper Companies nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.


Kazanç ve Gelir Geçmişi

NasdaqGS:COO Gelir, gider ve kazançlar (USD Millions )
TarihGelirKazançlarG+A GiderleriAr-Ge Giderleri
31 Jul 243,8043591,527154
30 Apr 243,7323401,521152
31 Jan 243,6662911,580145
31 Oct 233,5932941,530137
31 Jul 233,5142751,488130
30 Apr 233,4272881,467122
31 Jan 233,3803751,350116
31 Oct 223,3083861,338110
31 Jul 223,2194311,297107
30 Apr 223,1399481,238103
31 Jan 223,0299391,20598
31 Oct 212,9232,9451,14293
31 Jul 212,8452,9161,12293
30 Apr 212,6602,3551,05490
31 Jan 212,4652,24999793
31 Oct 202,43123899193
31 Jul 202,44127893791
30 Apr 202,54234397291
31 Jan 202,67245498188
31 Oct 192,65346799387
31 Jul 192,61344698186
30 Apr 192,59442795787
31 Jan 192,57136694487
31 Oct 182,53314097385
31 Jul 182,44312890781
30 Apr 182,33913186476
31 Jan 182,23017582372
31 Oct 172,13937379969
31 Jul 172,09634575668
30 Apr 172,05532973967
31 Jan 172,01629872667
31 Oct 161,96727471165
31 Jul 161,90425067963
30 Apr 161,85120766664
31 Jan 161,80119465664
31 Oct 151,79720466165
31 Jul 151,81019865967
30 Apr 151,78024165566
31 Jan 151,75825964866
31 Oct 141,71827063966
31 Jul 141,66129663264
30 Apr 141,64029762363
31 Jan 141,61129361861
31 Oct 131,58829661059

Kaliteli Kazançlar: COO yüksek kaliteli kazançlar sağlıyor.

Büyüyen Kar Marjı: COO 'nin mevcut net kar marjları (9.4%) geçen yılın (7.8%) sinden daha yüksektir.


Serbest Nakit Akışı ve Kazanç Analizi


Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: COO şirketinin kazançları son 5 yılda yılda 14.7% oranında azaldı.

Büyüme Hızlandırma: COO 'un son bir yıldaki kazanç büyümesi ( 30.5% ) 5 yıllık ortalamasını (yıllık -14.7% ) aşıyor.

Kazançlar vs. Sektör: COO geçen yılki kazanç büyümesi ( 30.5% ) Medical Equipment sektörünün 7.9% değerini aştı.


Özkaynak Getirisi

Yüksek ROE: COO 'nin Özsermaye Getirisi ( 4.5% ) düşük olarak değerlendiriliyor.


Varlık Getirisi


Kullanılan Sermaye Getirisi


Geçmişte güçlü performans gösteren şirketleri keşfedin